Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 16, 2015, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $101.50 to $30,000,001.88.

Highlighted Stocks Traded by Insiders:

Albany Molecular Research (AMRI) - FREE Research Report

Hagen Steven R, who is SVP Manufacturing & Pharmaceut at Albany Molecular Research, sold 441 shares at $18.79 on March 16, 2015. Following this transaction, the SVP Manufacturing & Pharmaceut owned 31,200 shares meaning that the stake was reduced by 1.39% with the 441-share transaction.

The shares most recently traded at $18.58, down $0.21, or 1.13% since the insider transaction. Historical insider transactions for Albany Molecular Research go as follows:

  • 4-Week # shares bought: 30,000
  • 4-Week # shares sold: 42,344
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 122,344
  • 24-Week # shares bought: 60,000
  • 24-Week # shares sold: 243,344

The average volume for Albany Molecular Research has been 546,200 shares per day over the past 30 days. Albany Molecular Research has a market cap of $614.6 million and is part of the health care sector and drugs industry. Shares are up 16.71% year-to-date as of the close of trading on Monday.

Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. The company has a P/E ratio of 157.1. Currently, there are 2 analysts who rate Albany Molecular Research a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMRI - FREE

TheStreet Quant Ratings rates Albany Molecular Research as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Albany Molecular Research Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Lithia Motors (LAD) - FREE Research Report

Becker Thomas R, who is Director at Lithia Motors, bought 516 shares at $91.00 on March 16, 2015. Following this transaction, the Director owned 62,000 shares meaning that the stake was boosted by 0.84% with the 516-share transaction.

The shares most recently traded at $94.64, up $3.64, or 3.85% since the insider transaction. Historical insider transactions for Lithia Motors go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares sold: 4,000

The average volume for Lithia Motors has been 279,400 shares per day over the past 30 days. Lithia Motors has a market cap of $2.2 billion and is part of the services sector and specialty retail industry. Shares are up 8.51% year-to-date as of the close of trading on Monday.

Lithia Motors, Inc. operates as an automotive franchisee and retailer of new and used vehicles in the United States. The stock currently has a dividend yield of 0.69%. The company has a P/E ratio of 17.9. Currently, there are 6 analysts who rate Lithia Motors a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LAD - FREE

TheStreet Quant Ratings rates Lithia Motors as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins. Get the full Lithia Motors Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Rouse Properties (RSE) - FREE Research Report

Harper Brian, who is Executive V.P., Leasing at Rouse Properties, sold 765 shares at $18.44 on March 16, 2015. Following this transaction, the Executive V.P., Leasing owned 74,701 shares meaning that the stake was reduced by 1.01% with the 765-share transaction.

The shares most recently traded at $18.73, up $0.29, or 1.55% since the insider transaction. Historical insider transactions for Rouse Properties go as follows:

  • 4-Week # shares bought: 19,750
  • 12-Week # shares bought: 19,750
  • 24-Week # shares bought: 24,750

The average volume for Rouse Properties has been 314,600 shares per day over the past 30 days. Rouse Properties has a market cap of $1.1 billion and is part of the financial sector and real estate industry. Shares are up 0.32% year-to-date as of the close of trading on Monday.

Rouse Properties, Inc. owns and manages regional malls in the United States. Its portfolio consists of 30 regional malls in 19 states totaling approximately 21 million square feet of retail and ancillary space. The company is based in New York, New York. Rouse Properties, Inc. The stock currently has a dividend yield of 3.81%. Currently, there are 2 analysts who rate Rouse Properties a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RSE - FREE

TheStreet Quant Ratings rates Rouse Properties as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in stock price during the past year and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. Get the full Rouse Properties Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null